MedPath

A comparative study of the effectiveness of Nanofat - PRP - Exosome therapy in the treatment of atrophic burn scars in patients treated with fractional CO2 laser: a double-blind randomized clinical trial

Phase 1
Recruiting
Conditions
Atrophic Burn Scar.
Scar conditions and fibrosis of skin
L90.5
Registration Number
IRCT20231211060333N1
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria

Patients who have been treated with fractional CO2 laser for the diagnosis of atrophic burn scars, but have not fully recovered.

Exclusion Criteria

Ages less than 18 years old or more than 50 years old
Atrophic scar created in the last 6 months
Conducting therapeutic intervention for atrophic scar in the last one month, except fractional CO2 laser
pregnancy
breastfeeding
Bleeding and coagulation disorders

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The healing rate of atrophic burn scars. Timepoint: The evaluation of patients will be conducted in three stages:1.At the beginning of the study and before the commencement of clinical interventions involving intralesional injections.2.Before receiving the second round of intralesional injections.3.Two months after the end of the treatment period. Method of measurement: Scale scar vancouver and biometric evaluations.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath